No recent contributors.
Be the first to edit!
| Domain Info
|
|---|
| |
| Map
|
|---|
| |
| AboutUs Badges
|
|---|
 |
Title edit
Signaling Pathways to Better Health - ARIAD
Description edit
Excerpted from the website description:
- ARIAD is developing breakthrough medicines that regulate cell-signaling pathways implicated in cancer. Our pipeline includes a series of small molecule product candidates that provide targeted and highly potent anti-cancer activity to treat solid tumors and hematologic cancers, as well as the spread of tumors to distant sites. Our lead candidate — deforolimus, a novel mTOR inhibitor—has been given fast track designation by the FDA for the treatment of soft-tissue and bone sarcomas.
Languages edit
English
